Recent News

• 06.05.2025 - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 05.14.2025 - Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights
• 05.02.2025 - Adverum Biotechnologies Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Recent Filings

• 05.23.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 05.20.2025 - SCHEDULE 13D General Statement of Acquisition of Beneficial Ownership
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.16.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.15.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 05.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.14.2025 - EX-99.1 EX-99.1
• 05.14.2025 - 8-K Current report
• 05.06.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors